• Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=801

    OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=802

    CBridge Capital, a healthcare-focused investment firm, recently announced its investment in Beijing Anhejialier Technology Co., Ltd. ("Anhejialier"), a leading company in the field of ultrasonic knives. This investment represents CBridge Capital's strong

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=803

    Innovative drug development company Lynk Pharma recently announced the successful closing of a $50 million in its Series B financing. The round was led by Lilly Asian Ventures, with participation from New Alliance Capital and HeDa Investment., as well as

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=804

    ZuoYi Technology, a leading domestic medical artificial intelligence system development company, recently announced the successful closing of a RMB 100 million Series B financing. The round was led by Qiming Venture Partners, with participation from well-

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=805

    New SORL successfully closes a RMB 500 million Series A financing. The round was led by HengXu Capital, with participation from SPIC, AutoCapital, Ruijian Capital, as well as local state-owned enterprises like Wenzhou Transportation Group and upstream sup

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=806

    Wenheyou successfully closed a significant Series B financing with investment from HongShan, IDG Capital, Warburg Pincus, Country Garden Venture Capital, GIC, and CEC Fund, amongst others. CEC Capital Group served as the exclusive financial advisor fo

  • Cancel
    Date：2021-08
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=808

    Berry Oncology recently announced the successful raising of nearly RMB 700 million in its Series B1 financing, led by China Merchants Capital, with support from existing shareholders Qiming Venture Partners and Legend Capital. Other investment institution

  • Cancel
    Date：2021-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=584

    M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.

  • Cancel
    Date：2021-07
    http://www.ceccapitalgroup.com/index.php?a=shows&catid=34&id=584

    M Stand, a trendy coffee chain brand, has announced its closing of Series B financing of over RMB500 million. The transaction was co-led by BA Capital and GenBridge Capital, two experienced venture capital investors in China’s consumer sector, and Gaorong Capital followed. Existing investors including CMC Capital Group and Challenjers Capital also participated. CEC Capital Group served as the lead financial advisor in this round. The transaction was the largest Series B financing in China’s heated coffee sector.